Information Provided By:
Fly News Breaks for October 30, 2015
IMPV
Oct 30, 2015 | 06:23 EDT
Topeka upgraded Imperva to Buy and increased its price target to $80 from $67 on shares.Analyst Frederick Ziegel said the Q3 earnings report was "breathtaking" and raised 2015 and 2016 estimates significantly. Ziegel believes Imperva is well positioned to drive 25%+ revenue growth with significant leverage.
News For IMPV From the Last 2 Days
There are no results for your query IMPV